SEC Filing | AtriCure, Inc.

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Shaffer Maureen

(Last)

(First)

(Middle)

6033 SCHUMACHER PARK DRIVE

(Street)

WEST CHESTER

45069

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/08/2007

3. Issuer Name and Ticker or Trading Symbol
AtriCure, Inc. [ ATRC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Vice President, Marketing

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	10/06/2005⁽¹⁾	10/06/2014	Common Stock	3,947	3.23	D
Stock Option (Right to Buy)	12/07/2006⁽²⁾	12/07/2015	Common Stock	5,000	13.18	D
Stock Option (Right to Buy)	09/06/2007⁽³⁾	09/06/2016	Common Stock	11,053	6.34	D

Explanation of Responses:

1. Exercisable cumulatively at a rate of 25% per annum commencing on October 6, 2005 (one year from the date of grant).

2. The option vests and is exercisable as to 25% of the shares on December 7, 2006 (one year from the date of grant) and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.

3. The option vests and is exercisable as to 25% of the shares on September 6, 2007 (one year from the date of grant) and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.

	/s/ Maureen A. Shaffer	02/16/2007
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

rrd130088_146266.html


                                POWER OF ATTORNEY

        KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes
and appoints Julie A. Piton and Sarah Wichman, and each of them, her true and
lawful attorney-in-fact to:

        (1) Execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer, director or 10% holder of AtriCure, Inc. (the
"Company"), a reporting company under the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), any and all Forms 3, 4 and 5 required to be filed
by the undersigned in accordance with Section 16(a) of the Exchange Act and the
rules thereunder;

        (2) Do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such Form 3, 4
and 5 and timely file such form with the United States Securities and Exchange
Commission and any stock exchange or similar authority; and

        (3) Take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned, pursuant to this Power of Attorney, shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in her
discretion.

        The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform all and every act and thing whatsoever
requisite, necessary, and proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or her substitute or substitutes, shall lawfully do or cause
to be done by virtue of this Power of Attorney and the rights and powers herein
granted. The undersigned acknowledges that no such attorney-in-fact, in serving
in such capacity at the request of the undersigned, is hereby assuming, nor is
the Company hereby assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act of 1934.

        This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorney-in-fact.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 16th day of February, 2007.


                                        By: /s/ Maureen A. Shaffer
                                            ------------------------------------
                                            Name:  Maureen A. Shaffer